triazoles has been researched along with cyclosporine in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (13.21) | 18.2507 |
2000's | 19 (35.85) | 29.6817 |
2010's | 23 (43.40) | 24.3611 |
2020's | 4 (7.55) | 2.80 |
Authors | Studies |
---|---|
Emery, DL; McClure, SJ | 1 |
Długosz, A | 1 |
Babu, VV; Shankaramma, SC; Sivanandaiah, KM | 1 |
Calne, RY; Luddington, R; Metcalfe, SM; St John Collier, DG; Watson, CJ | 1 |
Curtis, SL; Hatton, RC; Helms-Smith, KM | 1 |
Sayegh, MH; Vella, JP | 1 |
Bruhn, PS; Emery, RW; Lake, KD; Wright, DH | 1 |
Fujimura, A; Kawaguchi, A; Sugimoto, K | 1 |
Le Pogamp, P; Nilsson, LG; Romero, AJ; Wood, N | 1 |
Garton, T | 1 |
Garbino, J; Hirschel, B | 1 |
Ehlert, K; Groll, AH; Kolve, H; Paulussen, M; Vormoor, J | 1 |
Blankenship, JR; Heitman, J; Onyewu, C; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
Benjamin, DK; Heitman, J; Miller, JL; Perfect, JR; Schell, WA; Singh, N; Steinbach, WJ | 1 |
Boisseau-Garsaud, AM; Calès-Quist, D; Desbois, N; Diedhou, A; Dutriaux, C; Saint-Cyr, I | 1 |
Brandenburg, VM; Floege, J; Guetgemann, A; Ketteler, M; Riehl, J | 1 |
Blanton, A; Hercule, H; Nsaif, R; Oyekan, A | 1 |
Honda, M; Ichiyasu, H; Kohrogi, H; Matsumoto, M; Okamoto, S; Okamoto, T; Sato, K; Tsumori, K; Yamamura, A | 1 |
Bergman, A; Chen, L; Cote, J; Dilzer, S; Herman, G; Krishna, R; Larson, P; Lasseter, K; Wagner, J; Wang, A; Zeng, W | 1 |
Scheinfeld, N | 1 |
Gelone, S; Kantesaria, B; Krishna, G; Mant, TG; Martinho, M; Sansone-Parsons, A | 1 |
Book, BK; Lemonte, A; Pescovitz, MD; Smedema, M; Wheat, LJ; Zhuang, D | 1 |
Baillie, TA; Bleasby, K; Chen, Q; Colletti, A; Dean, DC; Evers, R; Hafey, M; Hagmann, WK; Lanza, TJ; Lin, LS; Magriotis, PA; Stearns, RA; Tang, W; Teffera, Y | 1 |
Li, D; Ma, CP; Qu, B; Sun, LH; Wan, J; Wang, W; Zhang, HQ; Zhang, SS | 1 |
Aisa, Y; Ikeda, Y; Kato, J; Mori, T; Nakamura, Y; Okamoto, S | 1 |
Dannaoui, E; Lortholary, O; Schwarz, P | 1 |
Higuchi, T; Kako, S; Kanda, Y; Kimura, S; Nakasone, H; Nishida, J; Okuda, S; Oshima, K; Sato, K; Sato, M; Tanaka, Y; Tanihara, A; Terasako, K; Yamazaki, R | 1 |
Blijlevens, NM; Brüggemann, RJ; Burger, DM; Donnelly, JP; Franke, B; Troke, PF | 1 |
Alangaden, GJ; Chandrasekar, PH; Manavathu, E; Narreddy, S; Revankar, SG | 1 |
Chen, G; Chen, W; Li, J; Stepkowski, SM; Wang, S; Xia, J; Ye, P; Zhang, K; Zhong, S | 1 |
Bergstresser, P; Chan, J; Dai, W; Dharamsi, JW; Gander, R; Ricotti, C; Soliman, S | 1 |
Afshari, NA; Goldhagen, BE; Majka, CP; Perfect, JR; Rebong, RA; Santaella, RM; Steinbach, WJ | 1 |
Gupta, S | 1 |
Arnan, M; Bermúdez, A; Caballero, T; Duarte, RF; Montes, C; Patiño, B; Sánchez-Ortega, I; Vázquez, L; Yáñez, L | 1 |
Chauhan, NM; Karuppayil, SM; Raut, JS; Shinde, RB | 1 |
Choi, YL; Joo, H; Kang, SW; Kim, E; Kim, TH; Kim, YH; Park, SJ; Shin, JG; Son, JH; Song, IS; Yoon, YC | 1 |
Andréasson, E; Bylund, J; Christenson, K; Dahlgren, C; Forsman, H; Karlsson, A; Önnheim, K | 1 |
McNeil, C | 1 |
Drechsler, M; Grommes, J; Soehnlein, O | 1 |
Abe, T; Fujii, S; Fujita, M; Iyama, S; Jomen, W; Kato, J; Kobune, M; Kuroda, H; Maeda, M; Matsuno, T; Miyanishi, K; Nagashima, K; Sakurai, T; Sato, M; Yamada, M | 1 |
Tohyama, K | 1 |
Bandeira, TJPG; Brilhante, RSN; Cordeiro, RA; Macedo, RB; Marques, FJF; Moreira, JLB; Rocha, MFG; Sidrim, JJC; Teixeira, CEC | 1 |
Liu, W; Ren, HY; Shi, YJ; Yuan, J | 1 |
Al-Ali, HK; Albrecht, S; Altamura, S; Bug, G; de Haas, K; Hubert, K; Jaekel, N; Kröger, N; Leismann, O; Lieder, K; Muckenthaler, MU; Niederwieser, D; Platzbecker, U; Stadler, M | 1 |
Akhtar, S; Desai, A; Groll, AH; Han, D; Howieson, C; Kato, K; Kowalski, D; Lademacher, C; Lewis, W; Mandarino, D; Pearlman, H; Townsend, R; Yamazaki, T | 1 |
Dong, Y; Liu, H; Liu, W; Miao, S; Ren, H; Shi, Y; Tang, B; Yin, Y | 1 |
Bae, H; Cho, SW; Do, HS; Han, J; Han, YM; Heo, HJ; Hong, SP; Im, I; Kim, I; Kim, KH; Kim, SJ; Ko, TH; Koh, BI; Koh, GY; Lee, S; Park, JH; Park, JS; Song, S; Youm, JB | 1 |
Dannaoui, E; Felske-Zech, H; Schwarz, P; Schwarz, PV | 1 |
Feng, WY; Hu, L; Huang, L; Li, TF; Liu, XM; Luo, XX; Ma, XL; Wu, CF | 1 |
Grigg, A; Hughes, CFM; Robinson, DH | 1 |
Aiello, G; Kobeissy, F; Kurup, M; Lin, F; Torres, I; Wang, KK; Yadikar, H; Yang, Z; Yost, R | 1 |
Bubalo, JS; Gu, TM; Le, H; Lewis, JS | 1 |
Cai, YP; Huang, HP; Liu, MB; Wang, Y; Wu, XM; Xu, BH; Zhu, LE | 1 |
3 review(s) available for triazoles and cyclosporine
Article | Year |
---|---|
A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine.
Topics: Animals; Antineoplastic Agents; Benzoates; Boronic Acids; Bortezomib; Cyclosporine; Dasatinib; Deferasirox; Humans; Iron Chelating Agents; Ophthalmic Solutions; Protein Kinase Inhibitors; Pyrazines; Pyrimidines; Randomized Controlled Trials as Topic; Skin Diseases; Skin Neoplasms; Thiazoles; Triazoles | 2007 |
Immunotherapies in diabetes mellitus type 1.
Topics: Abatacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Azathioprine; Basiliximab; Chaperonin 60; Cyclosporine; Daclizumab; Diabetes Mellitus, Type 1; Diet; Etanercept; Exenatide; Fatty Acids, Unsaturated; Glutamate Decarboxylase; Humans; Hypoglycemic Agents; Immunoconjugates; Immunoglobulin G; Immunosuppressive Agents; Insulin; Interferon-alpha; Interleukin 1 Receptor Antagonist Protein; Islets of Langerhans Transplantation; Niacinamide; Peptide Fragments; Peptides; Primary Prevention; Pyrazines; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rituximab; Secondary Prevention; Sitagliptin Phosphate; Tertiary Prevention; Triazoles; Venoms; Vitamin D; Vitamins | 2012 |
[Myelodysplastic syndromes: treatment strategy up-to-date].
Topics: Antilymphocyte Serum; Azacitidine; Benzoates; Cyclosporine; Cytarabine; Deferasirox; Disease Progression; Drug Discovery; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Iron Chelating Agents; Lenalidomide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Quality of Life; Risk Assessment; Thalidomide; Triazoles | 2014 |
6 trial(s) available for triazoles and cyclosporine
Article | Year |
---|---|
Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients.
Topics: Adult; Aged; Analysis of Variance; Antifungal Agents; Area Under Curve; Confidence Intervals; Cross-Over Studies; Cyclosporine; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Patients; Pyrimidines; Triazoles; Voriconazole | 2002 |
Effect of a single cyclosporine dose on the single-dose pharmacokinetics of sitagliptin (MK-0431), a dipeptidyl peptidase-4 inhibitor, in healthy male subjects.
Topics: Adenosine Deaminase Inhibitors; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Cyclosporine; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Glycoproteins; Humans; Hypoglycemic Agents; Kidney; Male; Pyrazines; Sitagliptin Phosphate; Triazoles | 2007 |
Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.
Topics: Adult; Antifungal Agents; Area Under Curve; Cross-Over Studies; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Tacrolimus; Triazoles | 2007 |
Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Biological Availability; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Allografts; Benzoates; Cyclosporine; Deferasirox; Female; Ferritins; Hematopoietic Stem Cell Transplantation; Humans; Iron; Iron Metabolism Disorders; Male; Middle Aged; Prospective Studies; Triazoles | 2016 |
Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults.
Topics: Adult; Area Under Curve; Cyclosporine; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Middle Aged; Mycophenolic Acid; Nitriles; Prednisolone; Pyridines; Sirolimus; Tacrolimus; Triazoles; Young Adult | 2017 |
44 other study(ies) available for triazoles and cyclosporine
Article | Year |
---|---|
Studies on the inhibition of rejection of Trichostrongylus colubriformis larvae from immune sheep.
Topics: Animals; Azepines; Chlorpheniramine; Cyclosporine; Dexamethasone; Indomethacin; Larva; Piroxicam; Rejection, Psychology; Sheep; Sheep Diseases; Theophylline; Triazoles; Trichostrongylosis; Trichostrongylus | 1995 |
Synthesis and biological activity of pyrimidobenzodiazepine derivatives. New ring systems: triazolo- and tetrazolo-pyrimido-benzodiazepines.
Topics: Animals; Antibody Formation; Antineoplastic Agents; Antiviral Agents; Benzodiazepinones; Cells, Cultured; Cyclosporine; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; HIV-1; Humans; Immunoglobulin M; Immunosuppressive Agents; Mice; Spleen; Tetrazoles; Triazoles; Tumor Cells, Cultured | 1995 |
Synthesis of peptides mediated by KOBt.
Topics: Amino Acid Sequence; Amino Acids; Cyclosporine; Enkephalins; Fluorenes; Molecular Sequence Data; Peptide Fragments; Potassium Compounds; Triazoles | 1994 |
The platelet-activating factor antagonist WEB 2170. Its beneficial effect on dog renal allograft survival.
Topics: Animals; Azepines; Cyclosporine; Dogs; Drug Therapy, Combination; Graft Survival; Immunosuppression Therapy; Kidney Transplantation; Platelet Activating Factor; Survival Analysis; Transplantation, Homologous; Triazoles | 1993 |
Apparent interaction between nefazodone and cyclosporine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Piperazines; Triazoles | 1996 |
Interactions between cyclosporine and newer antidepressant medications.
Topics: Antidepressive Agents, Second-Generation; Cyclosporine; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Female; Fluvoxamine; Humans; Kidney Transplantation; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles | 1998 |
Nefazodone and cyclosporine drug-drug interaction.
Topics: Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Oxidoreductases, N-Demethylating; Piperazines; Triazoles | 1999 |
Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephrotoxicity.
Topics: Animals; Azepines; Cyclosporine; Dose-Response Relationship, Drug; Endothelin-1; Hemodynamics; Immunosuppressive Agents; Kidney; Male; Platelet Activating Factor; Rats; Rats, Wistar; Thromboxane B2; Triazoles | 2001 |
Nefazodone and cyp450 3a4 interactions with cyclosporine and tacrolimus1.
Topics: Alanine Transaminase; Antidepressive Agents, Second-Generation; Aspartate Aminotransferases; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Hepatitis C; Humans; Liver Transplantation; Male; Mixed Function Oxygenases; Piperazines; Substance-Related Disorders; Tacrolimus; Triazoles | 2002 |
New drugs, old drugs - dear drugs, cheap drugs.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Marrow Transplantation; Caspofungin; Cyclosporine; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole | 2002 |
Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Calcineurin; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Drug Interactions; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2004 |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Echinocandins; Humans; Immunosuppressive Agents; Lipopeptides; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2004 |
[Subcutaneous phaeohyphomycosis due to Exophiala spinifera in a renal transplant recipient].
Topics: Antifungal Agents; Cyclosporine; Exophiala; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Leg; Middle Aged; Mycoses; Prednisone; Pyrimidines; Triazoles; Voriconazole | 2005 |
Unclear fever 7 weeks after renal transplantation in a 56-year-old patient.
Topics: Abscess; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy, Fine-Needle; Caspofungin; Contraindications; Cyclosporine; Delayed Graft Function; Drug Interactions; Echinocandins; Fever of Unknown Origin; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipopeptides; Male; Middle Aged; Mycophenolic Acid; Peptides, Cyclic; Postoperative Complications; Prednisone; Pyrimidines; Radionuclide Imaging; Stenotrophomonas maltophilia; Surgical Wound Infection; Thyroiditis; Triazoles; Ultrasonography; Voriconazole | 2006 |
Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat.
Topics: Amidines; Animals; Arginine; Blood Pressure; Bradykinin; Cyclosporine; Cytochrome P-450 Enzyme System; Endothelin-1; Hydroxyeicosatetraenoic Acids; Kidney; Male; Microsomes; Nitric Oxide; Nitroprusside; Phenylephrine; Rats; Rats, Sprague-Dawley; Triazoles | 2006 |
[Successful treatment by voliconazole for pulmonary and adductor magnus muscle aspergillosis induced by immunosuppressive therapy for hypersensitivity pneumonia].
Topics: Aged; Alveolitis, Extrinsic Allergic; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclosporine; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Fungal; Myositis; Opportunistic Infections; Prednisolone; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Effect of calcineurin inhibitors on posaconazole blood levels as measured by the MVista microbiological assay.
Topics: Antifungal Agents; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; False Positive Reactions; Graft vs Host Disease; Humans; Immunosuppressive Agents; Microbiological Techniques; Sirolimus; Tacrolimus; Triazoles | 2008 |
Importance of mechanistic drug metabolism studies in support of drug discovery: A case study with an N -sulfonylated dipeptide VLA-4 antagonist in rats.
Topics: Animals; Cells, Cultured; Cyclosporine; Dogs; Inactivation, Metabolic; Integrin alpha4beta1; Microsomes, Liver; Organic Anion Transporters, Sodium-Independent; Phenylalanine; Rats; Rats, Sprague-Dawley; Solute Carrier Organic Anion Transporter Family Member 1B3; Time Factors; Triazoles | 2008 |
A novel benzotriazole derivative inhibits proliferation of human hepatocarcinoma cells by increasing oxidative stress concomitant mitochondrial damage.
Topics: Antineoplastic Agents; Antioxidants; Ascorbic Acid; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclosporine; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Reactive Oxygen Species; Time Factors; Triazoles | 2008 |
Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
Topics: Adult; Antifungal Agents; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Statistics, Nonparametric; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2009 |
In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cyclosporine; Drug Interactions; Immunosuppressive Agents; Itraconazole; Microbial Sensitivity Tests; Mucorales; Rhizopus; Sirolimus; Tacrolimus; Thiazoles; Triazoles | 2009 |
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Chemical Analysis; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Transplantation; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2010 |
In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes.
Topics: Antifungal Agents; Calcineurin; Cyclosporine; Drug Interactions; Humans; Mucorales; Sirolimus; Tacrolimus; Triazoles | 2010 |
CCR5 blockade in combination with cyclosporine increased cardiac graft survival and generated alternatively activated macrophages in primates.
Topics: Animals; Binding, Competitive; CCR5 Receptor Antagonists; Cell Differentiation; Cells, Cultured; Coculture Techniques; Cyclohexanes; Cyclosporine; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Lymphocyte Culture Test, Mixed; Macaca mulatta; Macrophage Activation; Macrophages; Male; Maraviroc; PPAR gamma; Protein Binding; Receptors, CCR5; Triazoles; Up-Regulation | 2011 |
Cutaneous fusariosis developing in a post-irradiation site.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Debridement; Dermatomycoses; Female; Fusarium; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg Ulcer; Lymphoma, Non-Hodgkin; Opportunistic Infections; Postoperative Complications; Prednisone; Pyrimidines; Radiodermatitis; Radiotherapy; Skin Neoplasms; Triazoles; Voriconazole | 2011 |
Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Biguanides; Calcineurin Inhibitors; Corneal Ulcer; Cyclosporine; Disinfectants; Drug Synergism; Eye Infections, Fungal; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Prospective Studies; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2011 |
Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Transfusion; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Lymphoproliferative Disorders; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Triazoles; Young Adult | 2012 |
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Cyclosporine; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pharmacokinetic effect of voriconazole on cyclosporine in the treatment of aspergillosis after renal transplantation.
Topics: Adult; Antiviral Agents; Aspergillosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Pyrimidines; Triazoles; Voriconazole | 2012 |
Reactivation of desensitized formyl peptide receptors by platelet activating factor: a novel receptor cross talk mechanism regulating neutrophil superoxide anion production.
Topics: Actins; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cells, Cultured; Cyclosporine; Cytochalasin B; Cytoskeleton; Gelsolin; Humans; Marine Toxins; NADPH Oxidases; Neutrophils; Oligopeptides; Oxazoles; Peptide Fragments; Platelet Activating Factor; Receptors, Formyl Peptide; Superoxides; Thiazolidines; Triazoles | 2013 |
Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants.
Topics: Acute Disease; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Chronic Disease; Clinical Trials as Topic; Cyclohexanes; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydroxamic Acids; Immunosuppressive Agents; Maraviroc; Methotrexate; Pentostatin; Peripheral Blood Stem Cell Transplantation; Pyrazines; Quality of Life; Tacrolimus; Triazoles; Vorinostat | 2013 |
CCR5 and FPR1 mediate neutrophil recruitment in endotoxin-induced lung injury.
Topics: Acute Lung Injury; Animals; CCR5 Receptor Antagonists; Cell Movement; Cells, Cultured; Cyclohexanes; Cyclosporine; Humans; Lipopolysaccharides; Lung; Male; Maraviroc; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Receptors, CCR2; Receptors, CCR5; Receptors, Formyl Peptide; Triazoles | 2014 |
[Hematologic improvement with deferasirox following tandem antithymocyte globulin treatment in a transfusion-dependent patient with severe aplastic anemia].
Topics: Anemia, Aplastic; Antilymphocyte Serum; Benzoates; Blood Transfusion; Cyclosporine; Deferasirox; Humans; Iron Chelating Agents; Male; Middle Aged; Transfusion Reaction; Treatment Outcome; Triazoles | 2013 |
The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cyclosporine; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2014 |
Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model.
Topics: Animals; CCR5 Receptor Antagonists; Cyclohexanes; Cyclosporine; Cytokines; Disease Models, Animal; Drug Synergism; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Immunosuppressive Agents; Intestines; Liver; Male; Maraviroc; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CCR5; Receptors, CCR7; Receptors, CXCR3; Triazoles | 2015 |
CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function.
Topics: Animals; CCR5 Receptor Antagonists; Cyclohexanes; Cyclosporine; Cytokines; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Immunosuppressive Agents; Liver; Male; Maraviroc; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CCR5; T-Lymphocytes; Triazoles | 2016 |
Generation of PDGFRα
Topics: Amides; Aniline Compounds; Animals; Antioxidants; Cell Differentiation; Cell Line; Cells, Cultured; Chromans; Cyclosporine; Enzyme Inhibitors; Humans; Mice; Myoblasts; Myocytes, Cardiac; Pluripotent Stem Cells; Pyridines; Receptor, Platelet-Derived Growth Factor alpha; Triazoles | 2017 |
In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales.
Topics: Antifungal Agents; Cyclosporine; Immunosuppressive Agents; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Nitriles; Pyridines; Sirolimus; Tacrolimus; Triazoles | 2019 |
Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.
Topics: Adolescent; Antifungal Agents; Asian People; Body Weight; Child; Child, Preschool; Cyclosporine; Cytochrome P-450 CYP3A; Drug Monitoring; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Models, Biological; Polymorphism, Genetic; Transplantation, Homologous; Triazoles | 2019 |
Optimal oral cyclosporin dosing with concomitant posaconazole post allogeneic stem cell transplantation.
Topics: Antifungal Agents; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Retrospective Studies; Triazoles | 2020 |
Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
Topics: Animals; Cell Line; Cyclosporine; Glycogen Synthase Kinase 3; Lithium Chloride; Mice; Models, Biological; Okadaic Acid; Phosphorylation; Protein Kinase Inhibitors; Protein Multimerization; Rats; Tauopathies; Triazoles | 2020 |
Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations.
Topics: Antifungal Agents; Cyclosporine; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Nitriles; Pyridines; Retrospective Studies; Tacrolimus; Triazoles | 2022 |
Effect of posaconazole on the concentration of intravenous and oral cyclosporine in patients undergoing hematopoietic stem cell transplantation.
Topics: Administration, Intravenous; Administration, Oral; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Retrospective Studies; Triazoles | 2022 |